ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

How Tumor Boards Can Improve Care for Patients with Head, Neck Cancer

by Thomas R. Collins • June 8, 2015

  • Tweet
  • Email
Print-Friendly Version

During the Triological Society session “Tumor Board: Multidisciplinary Care of Head and Neck Cancer Patients,” veterans of the head and neck cancer field discussed how they use tumor boards, a treatment planning approach that involves experts from multiple specialties who review and discuss the condition and management options of a patient.

You Might Also Like

  • Chemoradiation vs. Surgery: Which is Better for Head and Neck Cancer?
  • Acupuncture May Improve Pain and Xerostomia After Head and Neck Cancer Surgery
  • Patient Navigators Promote Timely, Efficient Care for Patients with Head and Neck Cancers
  • Head and Neck Cancer Patients Who Don’t Drink or Smoke Have Worse Outcomes
Explore This Issue
June 2015

The panelists focused on how the approach has helped improve care quality and increased the value of care provided at their respective centers.

Tumor Board Value

Randal Weber, MD, chair of head and neck surgery at the University of Texas MD Anderson Cancer Center in Houston, discussed how his center is examining its own multidisciplinary tumor care to make sure it is providing value to patients.

Value, he reminded the audience, can be seen as a simple calculation proposed by Harvard economist Michael Porter, PhD: outcome divided by the cost of care.

An important metric to look at, Dr. Weber said, is “treatment package time”—the time between surgery or the start of radiation-chemotherapy and the final treatment. A 2002 study concluded that, in cases involving multi-modality therapy, treatment that extends beyond 100 days can have a negative effect on prognosis and survival (Head Neck. 2002;24:115-126). “These are the types of metrics that we try to capture to make sure that we are delivering care efficiently and within the prescribed treatment time,” Dr. Weber said.

They’ve also looked at performance indicators, divided into high-acuity and low-acuity cases—numbers such as hospital stays of two or more days for low-acuity cases and more than 11 days for high-acuity, blood use, and readmissions within 30 days. MD Anderson presented each of its surgeons with their own numbers in these types of categories and, anonymously, with those of their peers.

A year later, when the hospital examined those numbers again, they’d improved—often significantly—or at least had not gotten worse. One finding was that even though metrics such as length of stay and return to the operating room improved, blood use increased. The center is now conducting research to determine the reasons for that increase.

When it comes to cost, the main drivers are the treatment modalities and co-morbid conditions, not disease site or stage, Dr. Weber said. “You have to know your cost of care before you can enter into a bundled payment scheme, and you have to maintain a reasonable margin because if there’s no margin, there’s no mission,” he said. MD Anderson has built in a stop-loss on cases that are extreme outliers, he said.

Palliative Care Specialists

Jonas Johnson, MD, professor and chair of otolaryngology at the University of Pittsburgh School of Medicine, made powerful remarks on acknowledging when patients may have hit the end of the line with aggressive treatment. In those cases, having a palliative care representative on a tumor board is immensely helpful, he said.

Pages: 1 2 3 4 | Single Page

Filed Under: Features, Head and Neck, Practice Focus Tagged With: cancer, COSM, tumor boardIssue: June 2015

You Might Also Like:

  • Chemoradiation vs. Surgery: Which is Better for Head and Neck Cancer?
  • Acupuncture May Improve Pain and Xerostomia After Head and Neck Cancer Surgery
  • Patient Navigators Promote Timely, Efficient Care for Patients with Head and Neck Cancers
  • Head and Neck Cancer Patients Who Don’t Drink or Smoke Have Worse Outcomes

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Vertigo in the Elderly: What Does It Mean?
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Is the Training and Cost of a Fellowship Worth It? Here’s What Otolaryngologists Say
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Why Virtual Grand Rounds May Be Here to Stay
    • Otolaryngologist Leverages His Love of Pinball into Second Business
    • These New Imaging Advances May Help to Protect Parathyroids
    • Is the Training and Cost of a Fellowship Worth It? Here’s What Otolaryngologists Say
    • Which Otologic Procedures Poses the Greatest Risk of Aerosol Generation?

Polls

Have you used 3D-printed materials in your otolaryngology practice?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.